Palisade Bio Inc. (PALI)
NASDAQ: PALI
· Real-Time Price · USD
0.63
-0.02 (-2.82%)
At close: Sep 04, 2025, 11:08 AM
-2.82% (1D)
| Bid | 0.46 |
| Market Cap | 5.71M |
| Revenue (ttm) | 4K |
| Net Income (ttm) | -11.85M |
| EPS (ttm) | -3.64 |
| PE Ratio (ttm) | -0.17 |
| Forward PE | -0.53 |
| Analyst | Buy |
| Ask | 0.63 |
| Volume | 155,970 |
| Avg. Volume (20D) | 2,212,396 |
| Open | 0.64 |
| Previous Close | 0.65 |
| Day's Range | 0.62 - 0.65 |
| 52-Week Range | 0.60 - 4.32 |
| Beta | 1.41 |
About PALI
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PALI
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PALI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
+6.07%
Palisade Bio shares are trading lower after the co...
Unlock content with
Pro Subscription
8 months ago
+68.57%
Palisade Bio shares are trading higher. The company announced the pricing of a $5 million underwritten public offering.
